EPCA-2: A highly specific serum marker for prostate cancer

Clinical Biochemistry

Volumn 45, Issue 7-8, 2012, Pages 600-

  Diamandis, Eletherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EARLY PROSTATE CANCER ANTIGEN 2; TUMOR MARKER; UNCLASSIFIED DRUG;

LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER;

CARCINOMA; HUMANS; MALE; MASS MEDIA; PROSTATIC NEOPLASMS; RESEARCH;

EID: 84860140883     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.02.019     Document Type: Letter

References (3)

1. Leman E.S., Cannon G.W., Trock B.J., Sokoll L.J., Chan D.W., Marigold L., et al. EPCA-2: a highly specific serum marker for prostate cancer. Urology 2007, 69:714-720.
2. Diamandis E.P. Point: EPCA-2: a promising new serum biomarker for prostatic carcinoma?. Clin Biochem 2007, 40:1437-1439.
3. Leman E.S., Cannon G.W., Trock B.J., Sokoll L.J., Chan D.W., Marigold L., et al. Retracted: EPCA-2: a highly specific serum marker for prostate cancer. Urology 2012, 79:490.